Navigation Links
New Clinical Trial Shows Ascenta Skin Supplement Improves Skin's Resistance to UV Exposure
Date:8/7/2014

Los Angeles, CA (PRWEB) August 07, 2014

Ascenta Health is proud to announce that their revolutionary dietary supplement Ascenta Skin has been clinically shown to increase the skin’s natural protection against ultraviolet (UV) radiation, the leading cause of skin damage and accelerated skin aging.

A recent clinical trial studied the effects of UV exposure on participants who took 4 capsules of Ascenta Skin daily over an eight week period. The results were astounding! Participants displayed on average an 83.8% increase in the UV exposure needed to produce the skin reddening effect that we consider sunburn after just eight weeks.

Sunburn, or reddening of the skin, is an acute skin response to excess UV exposure. Caused by both UVA and UVB, sunburn can be painful and damaging to your skin after you have overexposed yourself to the sun. The accumulated damage accelerates skin aging characterized by an increase in sagging, wrinkling, uneven tone and sun spots. Ascenta Skin’s unique formula of 6 naturally derived active ingredients including Omega-3’s and powerful antioxidants may be the next step in sun protection from the inside out.

“Because Ascenta Skin works from the inside out it produces dramatic results not typically seen with topical skin care products. By simply adding Ascenta Skin to their current skin care regimen consumers are experiencing firmer, smoother, younger looking skin,” says Marc St-Onge, Ascenta Health CEO and creator of Ascenta Skin. “The added benefit of enhanced UV protection proves that healthy, beautiful skin starts from within.”

Conducted at Consumer Product Testing Company, a laboratory at the forefront of sun protection testing, the research featured 28 participants that completed the trial. These participants had their minimal erythemal dose (MED), the smallest dose of UV radiation that produces skin redness, recorded at the beginning of the study. After taking Ascenta Skin daily, their results were measured at the four and eight week markers.

During the first 4 weeks, their MED increased by an average of 39.1% which seemed significant until the results were in for the full eight week period. The increase after 8 weeks of 83.8% in the UV exposure needed to produce reddened skin supports the theory that Ascenta Skin has a UV protective effect on your skin.

Ascenta Skin features 6 active ingredients including DHA, EPA, GLA, Zeaxanthin, Lutein and Vitamin D. In addition to reducing the effects of UV damage, Ascenta Skin is government approved in Canada to increase skin elasticity and firmness, hydration, and reduce roughness and redness including atopic dermatitis. Ascenta Skin’s “Beauty from Within” formula is a game changer in the skin care industry, all natural, science based, amazing skin care results and now UV protection. While Ascenta Skin significantly increases your skin’s resistance to UV it is not intended as a replacement for appropriate use of topical sunscreens.

Ascenta Skin is available to purchase on AscentaSkin.com and at renowned spas throughout Canada. Coming soon to cities across America, Ascenta Skin is currently available at Space.NK.Apothecary in New York and Los Angeles.

For more information on Ascenta Skin and to see remarkable before and after images, please visit http://www.AscentaSkin.com.

Read the full story at http://www.prweb.com/releases/AscentaSkin/08/prweb12078745.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. First targeted nanomedicine to enter human clinical studies
2. Clinical insight improves treatment with new lung cancer drug
3. Clinical news alert from the American Academy of Orthopaedic Surgeons
4. NYU Langone experts present research, clinical advances at neurosurgeons meeting
5. Kroenke honored for outstanding contributions in clinical research training
6. Awards celebrate clinical research that can improve health and alleviate suffering
7. Association for Psychological Science, SAGE launch Clinical Psychological Science
8. URMC clinical trial tests new regimen for hypertension
9. Analysis Finds Clinical Trials Often Small, of Poor Quality
10. Automated insulin dosage titration system demonstrates positive clinical study results
11. Clinical news alert: Journal of the American Academy of Orthopaedic Surgeons May highlights
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... MALVERN, PA (PRWEB) , ... ... ... Management ("CSM"), a Great Point Partners ("GPP") portfolio company, today announced it ... Clinical Supplies ("TCS"). TCS was previously a subsidiary of Chiltern International ...
(Date:12/5/2016)... ... December 05, 2016 , ... The new knee compression ... looking to buy neoprene knee sleeves for lifting and any sport that ... heavily on two main aspects to provide a higher quality knee sleeve performance. Firstly ...
(Date:12/5/2016)... ... December 05, 2016 , ... A newly released ... improves the reproducibility and accuracy of placing precordial electrodes with little cognitive effort ... the last 60 years, studies have shown that single electrode misplacement is one ...
(Date:12/4/2016)... ... December 03, 2016 , ... Houston ... the 2016 Anti-Aging & Beauty Awards at The Aesthetic & Anti-aging Medicine ... Medicine European Congress (AMEC) brings together the industry’s leading scientific experts, speakers, ...
(Date:12/4/2016)... ... ... Responsible dental care hinges on regular brushing of the teeth. However, just brushing ... inspired an inventor from Las Vegas, Nev., to design the BRUSH PROPER. , ... bad techniques of brushing the teeth in order to prevent cavities," he said. "Children ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... M ichael ... Chairman   Mission Therapeutics, a drug discovery ... to treat cancer, neurodegenerative and other diseases, announces that Dr ... effective January 1 st 2017. Dr Colin Goddard ... Director in July 2015. Michael Moore , Mission,s Founder ...
(Date:12/4/2016)... DIEGO , Dec. 3, 2016 Johnson & ... on behalf of purchasers of Zimmer Biomet Holdings, Inc. (NYSE: ... 7, 2016 through October 31, 2016 (the "Class Period"). ... designs, manufactures, and markets orthopaedic reconstructive products, such as knee ... ...
(Date:12/4/2016)... 2016  Results from the Phase II SUSTAIN study ... reduced the median annual rate of sickle cell-related pain ... 2.98, p=0.010) in patients with or without hydroxyurea therapy ... being featured in the official press briefing at the ... Meeting and presented during the Plenary Scientific Session tomorrow ...
Breaking Medicine Technology: